This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: angiotensin-converting enzyme inhibitors

December 2020

Sacubitril-valsartan benefits in cancer therapy-related cardiac dysfunction

BJC Staff

Abstract

The patients who developed cardiotoxicity were treated with beta blockers (carvedilol), angiotensin-converting enzyme inhibitors (enalapril) or angiotensin receptor blockers (valsartan), aldosterone antagonists (eplerenone), digitalis and diuretics (furosemide), as needed. When patients remained symptomatic and met the PARADIGM-HF inclusion criteria, sacubitril/valsartan was started instead of enalapril or valsartan. Results showed that sacubitril/valsartan therapy produced an improvement in ventricular remodelling, diastolic dysfunction, and on symptoms, reflected in the New York Heart Association class and the six-minute walk test. The auth

| Full text
Optimising hypertension treatment: NICE/BHS guideline implementation and audit for best practice

March 2013 Br J Cardiol 2013;20(suppl 1): S1–S16 doi:10.5837/bjc.2013.s01

Optimising hypertension treatment: NICE/BHS guideline implementation and audit for best practice

Dr Terry McCormack, Dr Chris Arden, Dr Alan Begg, Professor Mark Caulfield, Dr Kathryn Griffith, Ms Helen Williams

Abstract

(more…)

| Full text

September 2006 Br J Cardiol 2006;13:347-50

Should cardiologists be interested in albuminuria?

Clive Weston, Achanthodi Vasudev, Daniel Obaid, Saatehi Bandhopadhay, Jiten Vora

Abstract

No content available

| Full text

May 2005 Br J Cardiol 2005;12:240-3

Heart failure management in primary care – the story so far

Sarah Jarvis

Abstract

No content available

| Full text

May 2004 Br J Cardiol 2004;11:243-45

Angiotensin-converting enzyme inhibitor prescription for heart failure in general practice, and the impact of a Rapid Access Heart Failure Clinic in Cardiff

Pitt O Lim, Gary Lane, Jayne Morris-Thurgood, Michael P Frenneaux

Abstract

No content available

| Full text

September 2002 Br J Cardiol 2002;9:481-7

GP use of beta blockers in heart failure

Mike Mead

Abstract

No content available

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now